Antiplatelet de-escalation after complex PCI: when and how? - EuroPCR

It is now understood that ischemia is not the only risk to consider, as bleeding also plays a significant role. This is why de-escalation is now recommended for patients with complex PCI, as all de-escalation strategies reduce bleeding risk. Discover more about the three different de-escalation scenarios in this #europcr 2024 interview with Jolanta Siller-Matula and Alessandro Sticchi: de-escalation by switching, by dose reduction, or by discontinuation, and learn when and how to use each of these options.
This video was filmed during #EuroPCR 2024.
See more videos here: www.pcronline.com/Cases-resou...
#pci
#antiplatelet
#deescalation
#bleeding